Summary
Part I of this article, which appeared in the previous issue of the Journal, covered general considerations, the physiology of the rectum, spreading of drugs into the colon, rectal absorption, partial avoidance of first-pass elimination, rate-controlled rectal delivery of drugs, irritation of the rectal mucosa and clinical applications of rectal administration, and discussed centrally acting drugs. In Part II, this discussion is extended to drugs which act peripherally and to methods of enhancing rectal drug absorption. The overall summary appeared in Part I.
Similar content being viewed by others
References
Abd Elbary A, Ibrahim SA, Elsorady H, Elmonem HA. Availability of paracetamol from different suppository bases, part 2: rectal absorption profile of paracetamol in humans. Pharmazeutische Industrie 45: 307–309, 1983
Abdel-Gawad AGH, El-Din EEZ. In vitro release and in vivo availability of chloroquine phosphate formulated suppositories. Drug Development and Industrial Pharmacy 15: 2681–2693, 1989
Accardo S, Galletti F, Gallotti A, Samanta E. Pharmacokinetics and relative bioavailability of isoxicam after oral and rectal administration in man. Current Therapeutic Research 33: 976–981, 1983
Acerbi L, de la Pierre L, Perletti L, Coppi G. Bioavailability studies of erythromycin administered by rectal route in paediatric patients. Chemioterapia 2: 200–202, 1983
Allgayer H, Kruis W, Eisenburg J, Paumgartner G. Comparative pharmacokinetics of sulphasalazine and sulphapyridine after rectal and oral administration to patients with ulcerative colitis. European Journal of Clinical Pharmacology 26: 275–277, 1984
Aungst B, Shen DD. Gastrointestinal absorption of toxic agents. In Rozman & Hänninen (Eds) Gastrointestinal toxicology, pp. 29–56, Elsevier Science Publishers B.V., Amsterdam, 1986
Barker EM, Aitchison JM, Cridland JS, Baker LW. Rectal administration of metronidazole in severely ill patients. British Medical Journal 287: 311–313, 1983
Bartle WR, Walker SE, Silverberg JDH. Rectal absorption of propylthiouracil. International Journal of Clinical Pharmacology, Therapy and Toxicology 26: 285–287, 1988
Becker P, Jamez R, Weber M. Concentrations plasmatiques de quelques anti-inflammatoires non-steroidiens, après administration rectale unique chez le volontaire sain. Acta Therapeutica 9: 333–343, 1983
Bergström BKV, Bertilson SO, Movin G. Clinical evaluation of rectally administered ampicillin in acute otitis media. Journal of International Medical Research 16: 376–385, 1988
Binder HJ, Sandle GI. Electrolyte absorption and secretion in the mammalian colon. In Johnson (Ed.) Physiology of the gastrointestinal tract, 2nd ed., pp. 1389–1418, Raven Press, New York, 1987
Björkman S, Gabrielsson J, Quaynor H, Corbey M. Pharmacokinetics of i.V. and rectal methohexitone in children. British Journal of Anaesthesia 59: 1541–1547, 1987
Bondesen S, Brønnum Schou J, Pedersen V, Rafiolsadat Z, Honoré Hansen S, et al. Absorption of 5-aminosalicylic acid from colon and rectum. British Journal of Clinical Pharmacology 25: 269–272, 1988
Breimer DD (Ed.) International Symposium on Rectal Diazepam for Acute Therapy, Frankfurt am Main, 1982, W. Zuckschwerdt Verlag GmbH, Munich, 1983
Breimer DD. The OSMET-osmotic pump in pharmaceutical research. Proceedings of the Pharm Tech Conference, September 10–12, pp. 189–193, Hyatt Cherry Hill, Cherry Hill, 1985
Breimer DD. Drug delivery system design inter-related with clinical pharmacology and drug metabolism. Yakuzaigaku 48: 75–85, 1988
Breimer DD, de Leede LGJ, de Boer AG. Rate-controlled rectal drug delivery. In Prescott & Nimmo (Eds) Rate control in drug therapy, pp. 54–64, Churchill Livingstone, Edinburgh, 1985
Brogden RN, Sorkin EM. Mesalazine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in chronic inflammatory bowel disease. Drugs 38: 500–523, 1989
Bülow PM, Ibraheem JJ, Paalzow G, Tfelt-Hansen P. Comparison of pharmacodynamic effects and plasma levels of oral and rectal ergotamine. Cephalgia 6: 107–111, 1986
Calvo MV, Lanao JM, Dominguez-Gil A. Bioavailability of rectally administered naproxen. International Journal of Pharmaceutics 38: 117–122, 1987
Campieri M, Lanfranchi GA, Boschi S, Brignola C, Bazzocchi G, et al. Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis: studies on rectal absorption and excretion. Gut 26: 400–405, 1985
Cann PA, Holdsworth CD. Systemic absorption from hydrocortisone foam enema in ulcerative colitis. Lancet 1: 922–923, 1987
Chiandussi L, Fonzo D, Franzone JS, Springolo V, Borella F, et al. Pharmacokinetics of co-tetroxazine in volunteers after rectal administration. Current Therapeutic Research 43: 503–507, 1988
Cid E, Mella F, Lucchini L, Cárcamo M, Monasterio J. Plasma concentrations and bioavailability of propranolol by oral, rectal and intravenous administration in man. Biopharmaceutics and Drug Disposition 7: 559–566, 1986
Clausen TG, Wolff J, Hansen PB, Larsen F, Rasmussen SN, et al. Pharmacokinetics of midazolam and β-hydroxy-midazolam following rectal and intravenous administration. British Journal of Clinical Pharmacology 25: 457–463, 1988
Cole ML, Kunka RL. Pharmacokinetics and bioavailability of theophylline following enema and suppository administration in man. Biopharmaceutics and Drug Disposition 5: 229–240, 1984
Davis SS, Burnham WR, Wilson P, O’Brien J. Use of adjuvants for enhancement of rectal absorption of cefoxitin in humans. Antimicrobial Agents and Chemotherapy 28: 211–215, 1985
De Blaey CJ, Polderman J. Rationale in the design of rectal and vaginal delivery forms of drugs. In Ariëns (Ed.) Drug Design, Vol. 9, Academic Press, London, 1980
De Boer AG, de Leede LGJ, Breimer DD. Drug absorption by sublingual and rectal routes. British Journal of Anaesthesia 56: 69–82, 1984
De Boer AG, Moolenaar F, de Leede LGJ, Breimer DD. Rectal drug administration: clinical pharmacokinetic considerations. Clinical Pharmacokinetics 7: 285–311, 1982
De Boer CN, Thornton JG. Prophylactic short course rectal metronidazole for cesarean section: a double-blind controlled trial of a simple low cost regimen. International Journal of Gynecology and Obstetrics 28: 103–107, 1989
De Kroon IFI, Langendijk PNJ, de Goede PNFC. Simultaneous determination of midazolam and its three hydroxy metabolites in human plasma by electron-capture gas chromatography without derivatization. Journal of Chromatography 491: 107–116, 1989
De Leede LGJ, de Boer AG. Rectal infusion of the model drug antipyrine with an osmotic delivery device. Biopharmaceutics and Drug Disposition 2: 131–136, 1981
De Leede LGJ, de Boer AG, Feijen CD, Breimer DD. Site specific rectal drug administration in man with an osmotic system: influence on ‘first-pass’ elimination of lidocaine. Pharmaceutical Research 129–134, 1984a
De Leede LGJ, de Boer AG, Pörtzgen E, Feijen J, Breimer DD. Rate-controlled rectal drug delivery in man with a hydrogel preparation. Journal of Controlled Release 4: 17–24, 1986
De Leede LGJ, de Boer AG, van Velzen SL, Breimer DD. Zero-order rectal delivery of theophylline in man with an osmotic system. Journal of Pharmacokinetics and Biopharmaceutics 10: 525–537, 1982
De Leede LGJ, Hug CC, de Lange S, de Boer AG, Breimer DD. Rectal and intravenous propranolol infusion to steady state: kinetics and β-receptor blockade. Clinical Pharmacology and Therapeutics 35: 148–155, 1984b
Del Tacca M, Danesi R, Senesi S, Gasperini M, Mussi A, et al. Penetration of clofoctol into human lung. Journal of Antimicrobial Chemotherapy 19: 679–683, 1987
Dew MJ, Cardwell M, Kidwai NS, Evans BK, Rhodes J. 5-Aminosalicylic acid in serum and urine after administration by enema to patients with colitis. Journal of Pharmacy and Pharmacology 35: 323–324, 1983
Dhillon S, Oxley J, Richens A. Bioavailability of diazepam after intravenous, oral and rectal administration in adult epileptic patients. British Journal of Clinical Pharmacology 13: 427–432, 1982
Dichter MA. The epilepsies and convulsive disorders. In Petersdorf et al. (Eds) Harrison’s principles of internal medicine, 10th ed., McGraw-Hill Inc., Tokyo, 1983
Diquet B, Nguyen-Huu JJ, Goursot J. Étude chez l’opéré digestif de la pharmacocinétique du métronidazole après administration intraveineuse et après administration rectale de la forme ovule. Thérapie 39: 323–332, 1984
Djimbo M, Moës AJ. Influence de l’interaction paracetamol-surfactifs non ioniques sur l’absorption rectale à partir de suppositoires. Journal de Pharmacie de Belgique 41: 393–401, 1986
Eandi M, Viano I, Ricci Gamalero S. Absolute bioavailability of paracetamol after oral or rectal administration in healthy volunteers. Arzneimittel-Forschung 34: 903–907, 1984
Eckardt VF, Kanzler G, Remmele W. Anorectal ergotism: another cause of solitary rectal ulcers. Gastroenterology 91: 1123–1127, 1986
Eller MG, Wright C, Della-Coletta AA. Absorption kinetics of rectally and orally administered ibuprofen. Biopharmaceutics and Drug Disposition 10: 269–278, 1989
Ellison NM, Lewis GO. Plasma concentrations following single doses of morphine sulfate in oral solution and rectal suppository. Clinical Pharmacy 3: 614–617, 1984
Farinotti R, Sainte-Marie D, Fichelle A, Dauphin A, Desmonts JM. Prophylaxie des infections postopératoires à germes anaérobies. Presse Médicale 13: 141–144, 1984
Farthing MJG, Rutland MD, Clark ML. Retrograde spread of hydrocortisone containing foam given intrarectally in ulcerative colitis. British Medical Journal 822–824, 1979
Forbes RB, Murray DJ, Dillman JB, Dull DL. Pharmacokinetics of two per cent rectal methohexitone in children. Canadian Journal of Anaesthesia 36: 160–164, 1989
Fredj G, Farinotti R, Hakkou F, Astier A, Dauphin A. Biodisponibilité de l’indométhacine par voie orale et par voie rectale. Journal de Pharmacie de Belgique 38: 105–108, 1983
Frijlink HW. Biopharmaceutical aspects of cyclodextrins, Ph.D Thesis, State University of Groningen, The Netherlands, 1990
Fujii T, Kubota A, Arai Y, Mizushima N. Rectal absorption of aminophylline suppositories prepared in hospital pharmacy: plasma and saliva levels of theophylline in humans. Japanese Journal of Hospital Pharmacy 8: 161–165, 1982
Gainant A, Sautereau D, Rigault M, Denax A, Nouaille Y, et al. Sténose rectale iatrogène par suppositoires de Véganine. Gastroenterologie Clinique et Biologique 11: 951, 1989
Gaudreault P, Guay J, Nicol O, Dupuis C. Pharmacokinetics and clinical efficacy of intrarectal solution of acetaminophen. Canadian Journal of Anaesthesia 35: 149–152, 1988
Graves NM, Holmes GB, Kriel RL, Jones-Saete C, Ong B, Ehresman DJ. Relative bioavailability of rectally administered phenobarbital sodium parenteral solution. DICP: Annals of Pharmacotherapy 23: 565–568, 1989
Graves NM, Kriel RL, Jones-Saete C, Cloyd JC. Relative bioavailability of rectally administered carbamazepine suspension in humans. Epilepsia 26: 429–433, 1985
Gregg MR, Jack DB, Kendall MJ. The pharmacokinetics of oxprenolol following oral and rectal dosing — a comparison of delivery sytems and routes of administration. Journal of Clinical Pharmacy and Therapeutics 12: 91–99, 1987
Guelen PJM, Janssen TJ, Brueren MM, Vree TB, Lipperts GJH. The pharmacokinetic profile of naproxen suppository in man. International Journal of Clinical Pharmacology, Therapy and Toxicology 26: 190–193, 1988
Hagenlocher M, Soliva M, Wittwer F, Ziegler WH, Speiser P. Absorption rate and bioavailability of acetaminophen from hard gelatin rectal capsules. Pharmazeutische Industrie 49: 1290–1294, 1987
Hanauer SB. 5-ASA enema therapy. Netherlands Journal of Medicine 35: S11–S20, 1989
Hanning CD, Vickers AP, Smith G, Graham NB, McNeil ME. The morphine hydrogel suppository. British Journal of Anaesthesia 61: 221–227, 1988
Hardy JG, Feely LC, Wood E, Davis SS. The application of gamma-scintigraphy for the evaluation of the relative spreading of suppository bases in rectal hard gelatin capsules. International Journal of Pharmaceutics 38: 103–108, 1987
Hardy JG, Lee SW, Clark AG, Reynolds JR. Enema volume and spreading. International Journal of Pharmaceutics 31: 151–155, 1986a
Hardy JG, Wood E, Clark AG, Reynolds JR. Colonic motility and enema spreading. European Journal of Nuclear Medicine 12: 176–178, 1986b
Harnoss B-M, Borner K, Borner E, Harnoss CM, Lode H, et al. Vergleichende Pharmakokinetik von Metronidazole nach intravenöser und rektaler Applikation. Zeitschrift für Antimikrobielle und Antineoplastische Chemotherapie 3: 65–71, 1985
Hayton WL. Rate-limiting barriers to intestinal drug absorption: a review. Journal of Pharmacokinetics and Biopharmaceutics 8: 321–334, 1980
Hellstern A, Hellenbrecht D, Sailer R, Gatzen M, Manus B, et al. Absolute bioavailability of metoclopramide given orally or by enema in patients with normal liver function or with cirrhosis of the liver. Arzneimittel-Forschung 37: 733–736, 1987
Holmes GB, Rosenberg WE, Graves NM, Remmel RP, Carlson GH, et al. Absorption of valproic acid suppositories in human volunteers. Archives of Neurology 46: 906–909, 1989
Hooker KD, DiPiro JT, Stanfield JA, DeLaurier GA, Lampert BM, Stewart JT, Knapp FF. Absorption of theophylline administered via colostomy. Clinical Pharmacy 8: 354–358, 1989
Houin G, Barre J, Tillement JP. Absolute intramuscular, oral, and rectal bioavailability of alizapride. Journal of Pharmaceutical Sciences 73: 1450–1453, 1984
Ibraheem JJ, Paalzow L, Tfelt-Hansen P. Low bioavailability of ergotamine tartrate after oral and rectal administration in migraine sufferers. British Journal of Clinical Pharmacology 16: 695–699, 1983
Issakainen J, Bourgeois BFD. Bioavailability of sodium valproate suppositories during repeated administration at steady state in epileptic children. European Journal of Pediatrics 146: 404–407, 1987
Jackson MJ. Drug transport across gastrointestinal epithelia. In Johnson (Ed.) Physiology of the gastrointestinal tract, 2nd ed., pp. 1597–1621, Raven Press, New York, 1987
Jantzen JPAH, Erdmann K, Witton PK, Klein AM. Der Einfluss der rektalen pH-Wertes auf die Resorption von Methohexital. Anaesthesist 35: 496–499, 1986
Järnerot G. Newer 5-aminosalicylic acid based drugs in chronic inflammatory bowel disease. Drugs 37: 73–86, 1989
Jay M, Beihn RM, Digenis GA, Deland FH, Caldwell L. Disposition of radiolabelled suppositories in humans. Journal of Pharmacy and Pharmacology 37: 266–268, 1985
Johannessen SI, Henriksen O, Munthe-Kaas AW, Salvesen B. Serum concentration profile studies of tablets and suppositories of valproate and carbamazepine in healthy subjects and patients with epilepsy. In Levy et al. (Eds) Metabolism of anti-epileptic drugs, pp. 61–71, Raven Press, New York, 1984
John VA, Monk JP, Hubbard J, Theobald W. Plasma profiles following single, oral, and rectal doses of phenylbutazone in healthy volunteers. Biopharmaceutics and Drug Disposition 4: 95–99, 1983
Jonkman JHG, van der Boon WJV, Schoenmaker R, Holtkamp A. Clinical pharmacokinetic comparison of two indomethacin containing suppositories with different véhicula. Arzneimittel-Forschung 34: 523–525, 1984
Jonsson T, Christensen CB, Jordening H, Frølund C. The bioavailability of rectally administered morphine. Pharmacology and Toxicology 62: 203–205, 1988
Kahela P, Laine E, Anttila M. A comparison of the bioavailability of paracetamol from a fatty and a hydrous suppository base and the effect of storage on the absorption in man. Drug Development and Industrial Pharmacy 13: 213–224, 1987
Kaji Y, Uekama K, Yoshikawa H, Takada K, Muranishi S. Selective transfer of 1-hexylcarbamoyl-5-fluorouracil into lymphatics by combination of β-cyclodextrin polymer complexation and absorption promoter in the rat. International Journal of Pharmaceutics 24: 79–89, 1985
Kanamoto I, Nakagawa T, Horikoshi I, Koizumi T. Pharmacokinetics of two rectal dosage forms of ketoprofen in patients after anal surgery. Journal of Pharmacobio-Dynamics 11: 141–145, 1988
Kanazawa O, Sengoku A, Kawai I. Atypical absence status occurred in a case of congenital muscular dystrophy (Fukuyama Type). A trial of therapy by rectal administration of valproate. Journal of the Japanese Epilepsy Society 3: 141–150, 1985
Kaniwa N, Ogata H, Aoyagi N, Takeda Y, Uchiyama M. Power analyses of moment analysis parameter in bioequivalence tests. Journal of Pharmaceutical Sciences 78: 1020–1024, 1989
Kestin IG, McIlvaine WB, Lockhart CH, Kestin KJ, Jones MA. Rectal methohexital for induction of anesthesia in children with and without rectal aspiration after sleep. Anesthesia and Analgesia 67: 1102–1104, 1988
Kleinbloesem CH, van Brummelen P, Danhof M, Faber H, Urquhart J, et al. Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans. Clinical Pharmacology and Therapeutics 41: 26–30, 1987
Kleinbloesem CH, van Harten J, de Leede LGJ, van Brummelen P, Breimer DD. Nifedipine kinetics and dynamics during rectal infusion to steady state with an osmotic system. Clinical Pharmacology and Therapeutics 36: 396–401, 1984
Klosterskov Jensen P, Abild K, Poulsen MN. Serum concentration of clonazepam after rectal administration. Acta Neurologica Scandinavica 68: 417–420, 1983
Knudsen FU. Plasma-diazepam in infants after rectal administration in solution and by suppository. Acta Paediatrica Scandinavica 66: 563–567, 1977
Knudsen FU. Rectal administration of diazepam in solution in the acute treatment of convulsions in infants and children. Archives of Disease in Childhood 54: 855–857, 1979
Knudsen FU. Successful intermittent diazepam prophylaxis in febrile convulsions: preliminary results of a prospective, controlled study. In Dam et al. (Eds) Advances in epileptology: XIIth International Symposium, pp. 165–168, Raven Press, New York, 1981
Kraus G, Frank S, Knoll R, Prestele H. Pharmakokinetische Untersuchungen nach intravenöser, intramuskulärer und rektaler Applikation von Methohexital bei Kindern. Anaesthesist 33: 266–271, 1984
Kurosawa S, Kurosawa N, Owada E, Matsuhashi N, Ito K. Rectal administration of nifedipine: haemodynamic effects and pharmacokinetics in hypertensives. Journal of International Medical Research 15: 121–127, 1987
Kurosawa N, Owada E, Ito K, Ueda K, Takahashi A, et al. Bioavailability of nifedipine suppository in healthy subjects. International Journal of Pharmaceutics 27: 81–88, 1985
Kuzemko JA, Le Cotonnec JY, Simpson-Laing JE, Weibel MA. Rectal absorption of a theophylline solution in asthma. Practitioner 229: 187–189, 1985
Langendijk P, van Loenen AC, Scheepstra GL, Terhoeven PA, Danhof M, et al. Effect and kinetics of midazolam after rectal administration. Symposium on Measurement and Kinetics of In Vivo Drug Effects, Noordwijk, The Netherlands, 1990
Lanthier P, Detry R, Debognie JC, Mahieu P, Vanheuverzwyn R. Lésions solitaires du rectum dues à des suppositoires associant acide acétylsalicylique et paracétamol. Gastroenterologie Clinique et Biologique 11: 250–253, 1987
Lee DAH, Taylor M, James VHT, Walker C. Rectally administered prednisolone: evidence for a predominantly local action. Gut 21: 215–218, 1980
Leuwer M, Rogowski Weber AK. Rektale Einleitung von Kindernarkosen; Thiopental, Thiobutobarbital, Hexobarbital und Methohexital im Vergleich. In Lehmann et al. (Eds) Intravenöse Narkosemittel, pp. 271–275, perimed Fachbuch-Verlagsgesellschaft mbH, Erlangen, 1984
Lie-A-Huen L, Kingma JH. Rectal absorption of flecainide acetate. European Journal of Clinical Pharmacology 35: 89–91, 1988
Liu LMP, Gaudreault P, Friedman PA, Goudsouzian NG, Liu PL. Methohexital plasma concentrations in children following rectal administration. Anesthesiology 62: 567–570, 1985
Lundgren S, Ekman A, Blombäck U. Rectal administration of diazepam in solution. Swedish Dental Journal 2: 161–166, 1978
Lunell E, Andersson K-E, Borgå O, Fagerström P-O, Johannesson N, et al. Absorption of enprofylline from the gastrointestinal tract in healthy subjects. European Journal of Clinical Pharmacology 27: 329–333, 1984
Lyon AJ, Mcintosh N. Rectal aminophylline in the management of apnoea of prematurity. Archives of Disease in Childhood 60: 38–41, 1985
Maggi GC, Renzetti I. Controlled study of the bioavailability of a naproxen salt by various routes of administration in healthy volunteers. Current Therapeutic Research 43: 303–310, 1988
Marteau P, Flourié B, Froguel E, Contou JF, Galian A, et al. Rectites secondaires à l’utilisation prolongée de suppositoires de dextropropoxyphène et de paracétamol: le risque persiste malgré le changement d’excipient. Gastroenterologie Clinique et Biologique 14: 102–103, 1990
Mather LE, Austin KL, Philpot CR, McDonald PJ. Absorption and bioavailability of oral erythromycin. British Journal of Clinical Pharmacology 12: 131–140, 1981
Matsumoto Y, Watanabe Y, Hori N, Matsumoto M, Iizuka F, et al. Therapeutic management of terminal cancer pain by morphine rectal delivery. Yakuzaigaku 50: 53–57, 1990
Mattila MAK, Ruoppi MK, Ahlström-Bengs E, Larni HM, Pekkola PO. Diazepam in rectal solution as premedication in children, with special reference to serum concentrations. British Journal of Anaesthesia 53: 1269–1272, 1981
McEvoy GK (Ed.) Drug Information 88, American Society of Hospital Pharmacists, Inc., Bethesda, 1988
Meijer RTW, Oostinga J, Schwietert HR, Scholtanus J, van Schoonhoven JC. A comparison of metronidazole serum concentrations after rectal administration of defined suppositories and intravenous administration. Pharmaceutisch Weekblad 119: 351–355, 1984
Michel P, Benoit I, Grellet J, Saux MC, Hazane C. Evaluation pharmacocinétique et clinique en pédiatrie d’un gel rectale hydrophile de sulfate d’atropine. Journal de Pharmacie Clinique 7: 4–19, 1988
Milligan N, Dhillon S, Oxley J, Richens A. Absorption of diazepam from the rectum and its effect on interictal spikes in the EEG. Epilepsia 23: 323–331, 1982
Milligan N, Dhillon S, Richens A, Oxley J. Rectal diazepam in the treatment of absence status: a pharmacodynamic study. Journal of Neurology, Neurosurgery and Psychiatry 44: 914–917, 1981
Milligan NM, Dhillon S, Griffiths A, Oxley J, Richens A. A clinical trial of single dose rectal and oral administration of diazepam for the prevention of serial seizures in adult epileptic patients. Journal of Neurology, Neurosurgery and Psychiatry 47: 235–240, 1984
Minagawa K, Miura H, Mizuno S, Shirai H. Pharmacokinetics of rectal diazepam in the prevention of recurrent febrile convulsions. Brain Development 8: 53–59, 1986
Minkov E, Lambov N, Kirchev D, Bantutova I, Tencheva J. Biopharmaceutical investigation of rectal suppositories: part 2. Pharmazie 40: 257–259, 1985
Möller H. Bioverfügbarkeit von rektalen Indometacin-Präparaten. Pharmazeutische Industrie 46: 285–291, 1984
Møller Jensen K, Grenabo L. Bioavailability of indomethacin after intramuscular injection and rectal administration of solution and suppositories. Acta Pharmacologica et Toxicologica 57: 322–327, 1985
Moolenaar F, Bakker S, Visser J, Huizinga T. Comparative biopharmaceutics of diazepam after single rectal, oral, intramuscular and intravenous administration in man. International Journal of Pharmaceutics 5: 127–137, 1980a
Moolenaar F, Cox HLM. Rectaal absorptieprofiel van codeïne vanuit zetpillen bereid met codeïnefosfaat en acetylsalicylzuur. Pharmaceutisch Weekblad 118: 818–821, 1983
Moolenaar F, Fiets G, Visser J, Meijer DKF. Preliminary study on the absorption profile after rectal and oral administration of methadone in human volunteers. Pharmaceutisch Weekblad — Scientific Edition 6: 237–240, 1984a
Moolenaar F, Grasmeijer G, Visser J, Meijer DKF. Rectal versus oral absorption of codeine phosphate in man. Biopharmaceutics and Drug Disposition 4: 195–199, 1983
Moolenaar F, Greving WJ, Huizinga T. Absorption rate and bioavailability of valproic acid and its sodium salt from rectal dosage forms. European Journal of Clinical Pharmacology 17: 309–315, 1980b
Moolenaar F, Insing JG, Bolhuis BG, Visser J. Absorption rate and bioavailability of promethazine from oral and rectal dosage forms. International Journal of Pharmaceutics 9: 353–359, 1981
Moolenaar F, Kaufmann BG, Visser J, Meijer DKF. Rectal absorption of methadone from dissolution-promoting vehicles. International Journal of Pharmaceutics 33: 249–252, 1986
Moolenaar F, Olthof L, Huizinga T. Absorption rate and bioavailability of paracetamol from rectal aqueous suspensions. Pharmaceutisch Weekblad — Scientific Edition 1: 25–30, 1979
Moolenaar F, Pronk J, Visser J, Meijer DKF. Rectal versus oral absorption of diflunisal in man. International Journal of Pharmaceutics 19: 161–167, 1984b
Moolenaar F, Yska JP, Visser J, Meijer DKF. Drastic improvement in the rectal absorption profile of morphine in man. European Journal of Clinical Pharmacology 29: 119–121, 1985
Morimoto K, Iwamoto Y, Katashima T, Takeeda T, Nakamoto Y, et al. Absorption and bioavailability of diclofenac after rectal administration of diclofenac-Na gel preparation in rat and man. Pharmaceutical Research 166–170, 1985
Mulder CJJ, Rondas AALM, Wiltink EHH, Tytgat GNJ. Topical corticosteroids in inflammatory bowel disease. Netherlands Journal of Medicine 35: S27–S34, 1989
Müller BW (Ed.) Suppositorien, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, 1986
Müller BW, Franzky HJ, Kölln CJ, Mengel W. Vergleichende Untersuchungen zur Bioverfügbarkeit von Paracetamol aus Suppositorien. Arzneimittel Forschung 34: 1319–1322, 1984
Murakami T, Yata N, Kamada A. Effect of isoxazolyl-penicillin on the rectal absorption of ampicillin in rabbits and humans. Chemical Pharmaceutical Bulletin 31: 1708–1713, 1983
Muranishi S. Characteristics of drug absorption via the rectal route. Methods and Findings in Experimental Clinical Pharmacology 6: 763–772, 1984
Netter FH. In Oppenheimer (Ed.) The Ciba collection of medical illustrations. Digestive system, lower digestive tract, Vol. 3, Pt 2, pp. 57–59, Ciba Pharmaceutical Co., Summit, 1973
Neumann G, Niv Y, Bat L, Abramowich D, Shemesh E. Effectiveness and absorption of rectal hydrocortisone acetate foam in nonspecific proctocolitis. Israeli Journal of Medical Sciences 25: 189–192, 1989
Neuvonen PJ, Tokola O. Bioavailability of rectally administered carbamazepine mixture. British Journal of Clinical Pharmacology 24: 839–841, 1987
Nishihata T, Kamada A, Sakai K, Yagi T, Kawamori R, et al. Effectiveness of insulin suppositories in diabetic patients. Journal of Pharmacy and Pharmacology 4: 799–801, 1989
Nishihata T, Okamura Y, Inagaki H, Sudho M, Kamada A, et al. Trials of rectal insulin suppositories in healthy humans. International Journal of Pharmaceutics 34: 157–161, 1986a
Nishihata T, Sudho M, Kamada A, Keigami M, Fujimoto T, et al. Investigation of sustained-release suppository of sodium diclofenac in humans. International Journal of Pharmaceutics 33: 181–186, 1986b
O’Hagan DT, Palin KJ, Davis SS. Intestinal absorption of proteins and macromolecules and the immunological response. CRC Critical Reviews of Therapeutic Drug Carrier Systems 4: 197–220, 1987
Okor RS, Nwankwo MU. Chloroquine absorption in children from polyethylene glycol base suppositories. Journal of Clinical Pharmacy and Therapeutics 13: 219–223; 1988
Olsson GL, Bejersten A, Feychting H, Palmér L, Petterson B-M. Plasma concentrations of atropine after rectal administration. Anaesthesia 38: 1179–1182, 1983
Ontyd J, Erckenbrecht JF, Berges W. Rektumstenosen bei Langzeittherapie mit Ergotamin. Deutsche Medizinische Wochenschrift 114: 1702–1705, 1989
Pannuti F, Vancini B, Comparsi R, Strocchi E, Camaggi CM. Rectal administration of medroxyprogesterone acetate in cancer patients: a pharmacokinetic study. Cancer Treatment Reports 70: 937–938, 1986
Parab PV, Ritschel WA, Coyle DE, Gregg RV, Denson DD. Pharmacokinetics of hydromorphone after intravenous, peroral and rectal administration to human subjects. Biopharmaceutics and Drug Disposition 9: 187–199, 1988
Perrin VL. Clinical pharmacokinetics of ergotamine in migraine and cluster headache. Clinical Pharmacokinetics 10: 334–352, 1985
Pozzi E, Ferrara A, Sardi A, Berti MA, Coppi G. Bioavailability studies on erythromycin administered by rectal and oral routes. Current Therapeutic Research 31: 530–535, 1982
Quaynor H, Corbey M, Björkman S. Rectal induction of anaesthesia in children with methohexitone. British Journal of Anaesthesia 57: 573–577, 1985
Ralph ED. Clinical pharmacokinetics of metronidazole. Clinical Pharmacokinetics 8: 43–62, 1983
Ramboer C, Verhamme M. Rectale sténose door analgetische suppositoria. Tijdschrift voor Geneeskunde 43: 925–928, 1987
Ravnborg M, Hasselstrøm L, Østengård D. Premedication with oral and rectal diazepam. Acta Anaesthesiologica Scandinavica 30: 132–138, 1986
Reid AS, Thomas NW, Palin KJ, Gould PL. Formulation of fenbufen suppositories, I: quantitative histological assessment of the rectal mucosa of rats following treatment with suppository bases. International Journal of Pharmaceutics 40: 181–185, 1987
Rey E, Nandakumaran M, Richard MO, Loose JP, d’Athis P, et al. Pharmacokinetics of flunitrazepam after single rectal administration in children. Developmental Pharmacology and Therapeutics 7: 206–212, 1984
Ritschel WA, Parab PV, Denson DD, Coyle DE, Gregg RV. Absolute bioavailability of hydromorphone after peroral and rectal administration in humans: saliva/plasma ratio and clinical effects. Journal of Clinical Pharmacology 27: 647–653, 1987
Rodrigues C, Lennard-Jones JE, English J, Parsons DG. Systemic absorption from prednisolone rectal foam in ulcerative colitis. Lancet 1: 1497, 1987
Rotenberg A, Chauveinc L, Rauh P, Rozenberg H, Nemeth J, Potet F. Lésions rectales secondaires à l’abus de suppositoires de dextropropoxyphène et paracétamol. Presse Médicale 17: 1545, 1988
Rylance GW, Poulton J, Cherry RC, Cullen RE. Plasma concentrations of clonazepam after single rectal administration. Archives of Disease in Childhood 61: 186–188, 1986
Saint-Maurice C, Meistelman C, Rey E, Esteve C, de Lauture D, et al. The pharmacokinetics of rectal midazolam for premedication in children. Anesthesiology 65: 536–538, 1986
Sandberg-Gertzén H, Ryde M, Järnerot G. Absorption and excretion of azodisal sodium and its metabolites in man after rectal administration of a single 2g dose. Scandinavian Journal of Gastroenterology 18: 571–575, 1983
Sanders SW, Haering N, Mosberg H, Jaeger H. Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing. European Journal of Clinical Pharmacology 30: 331–334, 1986
Scanabissi E, Dal Pozzo D, Franzoni E, Galloni C, Mengoli G, et al. Rectal administration of sodium valproate in children. Italian Journal of Neurological Sciences V: 189–193, 1984
Scaroni C, Mazzoni PL, D’Amico E, Benvenuti C, Hind ID. Pharmacokinetics of oral and rectal flurbiprofen in children. European Journal of Clinical Pharmacology 27: 367–369, 1984
Schwinghammer TL, Juhl RP. Comparison of the bioavailability of oral, rectal and intramuscular promethazine. Biopharmaceutics and Drug Disposition 5: 185–194, 1984
Shirai H, Miura H, Sunaoshi W. A clinical study on the effectiveness of intermittent therapy with rectal diazepam suppositories for the prevention of recurrent febrile convulsions and the development of epilepsy during the study period. Brain and Development 10: 201–202, 1988
Sjövall J, Westerlund D, Alván G, Magni L, Nord CE, et al. Rectal bioavailability of bacampicillin hydrochloride in man as determined by reversed-phase liquid chromatography. Chemotherapy 30: 137–147, 1984
Sugito K, Ogata H, Noguchi M, Kogure T, Takano M, et al. The spreading of radiolabelied fatty suppository bases in the human rectum. International Journal of Pharmaceutics 47: 157–162, 1988
Sutherland LR, Martin F, Greer S, Robinson M, Greenberger N, et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 92: 1894–1898, 1987
Swanson DR, Barclay BL, Wong PSL, Theeuwes F. Nifedipine gastrointestinal therapeutic system. American Journal of Medicine 83 (Suppl 6B): 3–9, 1987
Takahashi T, Mizusawa H, Kato T, Yamaguchi T. Preoperative irradiation and 5-fluorouracil suppository for carcinoma of the rectum. American Journal of Surgery 156: 58–62, 1988
Teunissen MWE, de Leede LGJ, Boeijinga JK, Breimer DD. Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state. Journal of Pharmacology and Experimental Therapeutics 233: 770–775, 1985a
Teunissen MWE, Kleinbloesem CH, de Leede LGJ, Breimer DD. Influence of cimetidine on steady state concentration and metabolite formation from antipyrine infused with a rectal osmotic mini pump. European Journal of Clinical Pharmacology 28: 681–684, 1985b
Theeuwes F. Rate controlled delivery by the oral and rectal route. In Breimer & Speiser (Eds) Topics in pharmaceutical sciences 1985, pp. 119–132, Elsevier Science Publishers B.V., Amsterdam, 1985
Theeuwes F. Triggered, pulsed and programmed drug delivery. In Prescott & Nimmo (Eds) Novel drug delivery and its therapeutic application, pp. 323–340, John Wiley & Sons Ltd., New York, 1989
Thompson JF, Pike JM, Chumas PD, Rundle JSH. Rectal diclofenac compared with pethidine injection in acute renal colic. British Medical Journal 229: 1140–1141, 1989
Tiel-Van Buul MMC, Mulder CJJ, van Royen EA, Wiltink EHH, Tytgat GNJ. Retrograde spread of mesalazine (5-aminosalicylic acid)-containing enema in patients with ulcerative colitis. Clinical Pharmacokinetics 20: 247–251, 1991
Tjandramaga TB, Verbesselt R, van Hecken A, de Schepper PJ. Comparative systemic bioavailability of rectal and oral preparations of microcrystalline theophylline. Current Medical Research and Opinion 6 (Suppl. 6): 142–150, 1979
Tukker JJ, Blankenstein MA, Nortier JWR. Comparison of bioavailability in man of tamoxifen after oral and rectal administration. Journal of Pharmacy and Pharmacology 38: 888–892, 1986
Van Buul MMC, Mulder CJJ, Wiltink EHH, van Royen EA, Tytgat GNJ. Retrograde spread of therapeutic enemas in patients with inflammatory bowel disease. Hepato-Gastroenterology 36: 199–201, 1989
Van der Meer YG, Benedek-Jaszmann LJ, van Loenen AC. Effect of high-dose progesterone on the pre-menstrual syndrome: a double-blind cross-over trial. Journal of Psychosomatic Obstetrics and Gynaecology 2: 220–222, 1983
Van der Meer YG, van Loenen AC, Loendersloot EW, Jaszmann LJB. Plasma progesterone levels after using high dose suppositories: a preliminary report. Pharmaceutisch Weekblad — Scientific Edition 4: 135–136, 1982
Van Hoogdalem EJ, de Boer AG, Breimer DD. Intestinal drug absorption enhancement: an overview. Pharmacology and Therapeutics 44: 407–443, 1989a
Van Hoogdalem EJ, Heijligers-Feijen CD, de Boer AG, Verhoef JC, Breimer DD. Rectal absorption enhancement of des-enkephalin-γ-endorphin (DEγE) by medium-chain glycerides and EDTA in conscious rats. Pharmaceutical Research 6: 91–95, 1989b
Van Hoogdalem EJ, Vermeij-Keers C, de Boer AG, Breimer DD. Topical effects of absorption enhancing agents on the rectal mucosa of rats in vivo. Journal of Pharmaceutical Sciences 79: 866–870, 1990
Van Hoogdalem EJ, Wackwitz ATE, de Boer AG, Cohen AF, Breimer DD. Rate-controlled rectal absorption enhancement of cefoxitin by co-administration of sodium salicylate or sodium octanoate in healthy volunteers. British Journal of Clinical Pharmacology 27: 75–81, 1989c
Vetrovec GW, Parker VE, Cole S, Procacci PM, Tabatznik B, et al. Nifedipine gastrointestinal therapeutic system in stable angina pectoris. American Journal of Medicine 83 (Suppl. 6B): 24–29, 1987
Vitti RA, Meyers F, Knight LC, Siegel JA, Malmud LS, et al. Quantitative distribution of radiolabeled 5-aminosalicylic acid enemas in patients with left-sided ulcerative colitis. Digestive Diseases and Sciences 34: 1792–1797, 1989
Vromans H, Moolenaar F, Visser J, Meijer DKF. Rectal absorption of metronidazole from polyethylene glycol suppositories. Pharmaceutisch Weekblad — Scientific Edition 6: 18–20, 1984
Walker R, Newman P, Candlish P, Hiller C, Seviour J. Absorption of diazepam in man following rectal administration of a suppository, solution and emulsion. Journal of Pharmacy and Pharmacology 34 (Suppl.): 33P, 1982
Walter RM, Bartle WR. Rectal administration of propylthiouracil in the treatment of Graves’ disease. American Journal of Medicine 88: 69–70, 1990
Walter-Sack I, Luckow V, Guserle R, Weber E. Untersuchungen der relativen Bioverfügbarkeit von Paracetamol nach Gabe von festen und flüssigen oralen Zubereitungen sowie rektalen Applikationsformen. Arzneimittel Forschung 39: 719–724, 1989
Westerling D, Andersson K-E. Rectal administration of morphine hydrogel: absorption and bioavailability in women. Acta Anaesthesiologica Scandinavica 28: 540–543, 1984
Wood E, Wilson CG, Hardy JG. The spreading of foam and solution enemas. International Journal of Pharmaceutics 25: 191–197, 1985
Yoshikawa H, Muranishi S, Kato C, Sezaki H. Bifunctional delivery system for selective transfer of bleomycin into lymphatics via enteral route. International Journal of Pharmaceutics 8: 291–302, 1981
Yoshikawa H, Satoh Y, Naruse N, Takada K, Muranishi S. Comparison of disappearance from blood and lymphatic delivery of human fibroblast interferon in rat by different administration routes. Journal of Pharmacobio-Dynamics 8: 206–210, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Hoogdalem, E.J., de Boer, A.G. & Breimer, D.D. Pharmacokinetics of Rectal Drug Administration, Part II. Clin. Pharmacokinet. 21, 110–128 (1991). https://doi.org/10.2165/00003088-199121020-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-199121020-00003